Alcidion Group Boosts FY25 Financial Guidance Amid Strong Performance

An update from Alcidion Group Limited ( (AU:ALC) ) is now available.

Alcidion Group Limited has upgraded its financial guidance for the fiscal year ending June 2025, expecting EBITDA to exceed $4.5 million, up from the previous forecast of over $3.0 million. This improvement is attributed to smaller contract upgrades, extensions, diligent cost management, and favorable foreign exchange movements. The company’s Miya platform continues to gain traction, leading to increased customer engagement and new opportunities, reinforcing Alcidion’s long-term value proposition and ability to address critical challenges in global hospital systems.

The most recent analyst rating on (AU:ALC) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on Alcidion Group Limited stock, see the AU:ALC Stock Forecast page.

More about Alcidion Group Limited

Alcidion Group Limited is a healthcare technology company focused on transforming healthcare with smart, intuitive technology solutions that enhance patient care efficiency and quality. The company offers a suite of software products and technical services, including its flagship product, Miya Precision, which supports interoperability, communication, and clinical decision-making in healthcare settings. Alcidion services over 400 hospitals and 87 healthcare organizations across the UK, Australia, and New Zealand, with plans for further geographical expansion.

Average Trading Volume: 1,401,650

Technical Sentiment Signal: Buy

Current Market Cap: A$122.2M

Learn more about ALC stock on TipRanks’ Stock Analysis page.